CitiusTech Appoints Sudhir Kesavan as Chief Operating Officer

2 years ago

PRINCETON, N.J.--(BUSINESS WIRE)--#COO--CitiusTech, a leading provider of healthcare technology services, solutions, and platforms, announced the appointment of Sudhir Kesavan as…

B-Secur Receives ISO 13485:2016 Certification

2 years ago

BELFAST, Northern Ireland--(BUSINESS WIRE)--#BiosensingInnovation--B-Secur, a global leader in biosensing algorithms, today announced that it has received ISO 13485:2016, the Quality…

Cannabinoid Biotech Leader FloraWorks to Present at Seed Showcase 2024 During J.P. Morgan Healthcare Conference

2 years ago

CEO Alleh Lindquist to Present the Company's Breakthrough Cannabinoid Research Approach For a New Generation of TherapeuticsPortland, Oregon--(Newsfile Corp. -…

Healthcare Industry Veteran Donald M. Casey Jr. Joins Board of Directors at Cannabinoid Biotech Leader FloraWorks

2 years ago

Portland, Oregon--(Newsfile Corp. - January 4, 2024) - FloraWorks Holdings Inc., a leading cannabinoid biotech company, announced the appointment of…

Issuance of New US Patent Bolsters IP Protection for Jaguar Health in the Treatment of Congenital Diarrheal Disorders (CDDs)

2 years ago

New patent issued for core rare disease target indication for crofelemerJaguar is supporting investigator-initiated proof-of-concept studies of crofelemer for the…

NanoViricides to Present at the Biotech Showcase in San Fransisco

2 years ago

SHELTON, CT / ACCESSWIRE / January 4, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a leader in the development…

Zevra Therapeutics Appoints Global Medical Leader, Adrian Quartel, M.D., FFPM, as Chief Medical Officer

2 years ago

CELEBRATION, Fla., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra or the Company), a rare disease therapeutics…

RespireRx Pharmaceuticals Inc. Announces the Publication of a Case Report in which KRM-II-81 Totally Suppressed Epileptiform Activity in Brain Tissue Surgically Removed from Epileptic Patient

2 years ago

Glen Rock, N.J., Jan. 04, 2024 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTC Pink Market: RSPI) (“RespireRx” or the “Company”),…

BriaCell Images Confirm Robust Anti-Tumor Activity in Patient with “Eye-Bulging” Metastatic Breast Cancer

2 years ago

Figure 1 Magnetic resonance imaging (MRI) of the orbital tumor. The top left MRI image shows the tumor in the…